Swiss Daybook: Takeda for Nycomed, Roche, Novartis, Syngenta

Takeda Pharmaceutical Co. agreed to buy Swiss drugmaker Nycomed for about 1 trillion yen ($12 billion), the Nikkei newspaper reported. An announcement will be made today, the newspaper said.

EQUITIES: *Roche and Merck & Co. will work together to market treatments for hepatitis C in the U.S. *Roche will present new personalized approaches for people with skin and lung cancer at the Annual Meeting of the American Society of Clinical Oncology *Novartis will provide a restated consolidated income statement data for 2010 and first quarter 2011 to reflect the new divisional structure following the Alcon merger *Swatch Group may create 500 to 700 jobs at a new production site in Bonfol, in Switzerland’s Jura region, over the medium- to long-term, Tages-Anzeiger newspaper reported, without saying from where it got the information *Lonza said it will expand its viral production capacity with the construction of a new cGMP clean room in Houston, Texas *Swiss central bank Vice President Thomas Jordan said concerns that the government’s so-called too-big-to-fail proposals will hurt lenders and undermine economic growth are “exaggerated and largely unfounded.” *Syngenta announced the launch of Vibrance, a seed treatment fungicide based on the new active ingredient sedaxane *Swiss Re declared the exchange offer successful, allowing it to go ahead with a new holding structure *Bucher Says Kuhn Group, John Deere to cooperate on large square balers *Lem Holding reported the termination of its shareholder buy- back program

WHAT TO WATCH: *Swisscanto holds media conference to present pension funds survey results at 10 a.m. in Zurich *Novartis holds webcast at 3:30 p.m. on divisional structure following Alcon merger

ECONOMY/POLITICS: *Swiss government holds regular meeting

MARKETS: *The SMI dropped 1 percent to 6,496.56 *The SPI fell 1.1 percent to 5,976.68 *The Stoxx Europe 600 Index slipped 1 percent to 277.28 *The MSCI Asia-Pacific Index climbed 1.3 percent to 135.60 at 7:26 a.m. Zurich time *Euro-franc traded at 1.2553 at 7:27 a.m. Zurich time

To contact the reporter on this story: Corinne Gretler in Zurich at cgretler1@bloomberg.net

To contact the editor responsible for this story: Dylan Griffiths at dgriffiths@bloomberg.net; Matthias Wabl at mwabl@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.